Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for oNKord in acute myeloid leukemia (Phase 1/Phase 2) evaluating safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• oNKord®

Snippet

Sponsor: Glycostem Therapeutics BV | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN